Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
CollabRx logo — company profile

CollabRx

Founded 2008 Venture round Total: $1.56M Health Care, Health and Wellness +1

General Information

Company Name CollabRx
Founded Year 2008
Industries Health Care, Health and Wellness, Information Technology
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with CollabRx. To contact CollabRx, visit collabrx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About CollabRx

CollabRx is a health care and information technology startup founded in 2008. The company harnesses information technology to guide personalized cancer treatment planning. Their focus is on integrating global knowledge on innovative therapies with insights from top cancer experts across the nation, initially targeting advanced cancers in patients who have exhausted standard treatment options. CollabRx received a $1.56M Venture Round investment on 14 April 2011 from CommerceNet. The company's innovative approach to personalized cancer treatment planning, coupled with its collaboration with healthcare experts, makes it an intriguing prospect for venture capital investment in the rapidly evolving intersection of healthcare and technology. This investment not only provides financial support but also signifies the confidence of prominent investors in CollabRx's vision and potential impact in revolutionizing cancer treatment through information technology.

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $1.56M 1
CommerceNet
CommerceNet
14 Apr 2011

CollabRx Alternatives & Competitors

View All Alternatives
CollabRx vs
Alliance for Cancer Gene Therapy
Alliance for Cancer Gene Therapy United States

Momentous change has happened, and a cancer-free future is possible -- thanks to cell and gene thera...

10 employees
Health Care, Health and Wellness
CollabRx vs
Acepodia
Acepodia United States

POWERFUL, ACCESSIBLE CELL THERAPIES FOR PATIENTS WITH CANCER

Series D
49 employees
Biotechnology, Health Care
CollabRx vs
Elicio Therapeutics
Elicio Therapeutics United States

Lymph-Node Targeted Immunotherapies

IPO
47 employees
Biotechnology, Health Care
View all alternatives

FAQ About CollabRx

CollabRx harnesses information technology to guide personalized cancer treatment planning by integrating global knowledge on innovative therapies with insights from top cancer experts across the nation, focusing initially on advanced cancers in patients who have exhausted standard treatment options.
CollabRx was founded in 2008.
CollabRx operates in Health Care, Health and Wellness and Information Technology.
CollabRx has completed 1 funding round, raising a total of $1.56M. The latest funding stage is Venture round.
Top alternatives and competitors to CollabRx include Alliance for Cancer Gene Therapy, Acepodia, Elicio Therapeutics, Odimma Therapeutics, Mersana Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CollabRx and Alliance for Cancer Gene Therapy are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for CollabRx, https://bouncewatch.com/company/collabrx, updated 11 September 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes